AVERA MCKENNAN
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $13M
- Transactions
- 1,462
- Companies
- 40
- Average per transaction
- $8,901
Who reported the payments
| Regeneron | $2,421,021 |
| Amgen | $1,831,884 |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,311,423 |
| Genentech, Inc. | $957,038 |
| AstraZeneca | $930,947 |
| Merck | $872,338 |
| Pfizer | $633,812 |
| Astrazeneca UK Limited | $495,678 |
| Novartis | $421,398 |
| Bristol Myers Squibb | $316,294 |
| Clovis Oncology, Inc. | $173,267 |
| Alkermes, Inc. | $168,164 |
| AbbVie | $162,374 |
| Daiichi Sankyo Inc. | $146,064 |
| E.r. Squibb & Sons, L.L.C. | $144,834 |
| Deciphera Pharmaceuticals Inc. | $140,694 |
| Gilead | $140,568 |
| Incyte Corporation | $135,649 |
| Tesaro, Inc. | $134,297 |
| Eli Lilly | $115,606 |
| Iovance Biotherapeutics, Inc. | $103,676 |
| Janssen Research & Development, LLC | $101,261 |
| ADC Therapeutics America, Inc. | $93,556 |
| GSK | $70,076 |
| National Marrow Donor Program | $63,595 |
| Trillium Therapeutics USA, LLC | $63,401 |
| Beone Medicines USA, Inc. | $61,685 |
| Medartis Inc. | $56,114 |
| Intuitive Surgical | $47,500 |
| Karyopharm Therapeutics Inc. | $45,628 |
| Siemens Medical Solutions USA, Inc. | $44,799 |
| Beigene, Ltd. | $38,399 |
| Stryker | $36,484 |
| Sage Therapeutics, LLC | $35,250 |
| Olympus America Inc. | $35,112 |
| Merck Healthcare Kgaa | $33,350 |
| TG Therapeutics, Inc. | $32,321 |
| Boehringer Ingelheim | $32,095 |
| Beone Medicines Ltd. | $31,650 |
| Genentech USA, Inc. | $27,000 |